Merck & Company Inc (MRK)vsJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)
MRK
Merck & Company Inc
$133.72
+0.69%
HEALTHCARE · Cap: $362.27B
ZJYL
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
$3.38
+1.20%
HEALTHCARE · Cap: $628.82M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 341483% more annual revenue ($67.38B vs $19.73M). ZJYL leads profitability with a 6.0% profit margin vs 3.6%. ZJYL trades at a lower P/E of 20.8x. MRK earns a higher WallStSmart Score of 42/100 (D).
MRK
Hold42
out of 100
Grade: D
ZJYL
Avoid15
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-56.0%
Fair Value
$85.13
Current Price
$133.72
$48.59 premium
Intrinsic value data unavailable for ZJYL.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 35.2%
Generating 5.5B in free cash flow
Reasonable price relative to book value
Areas to Watch
4.7% revenue growth
ROE of 5.5% — below average capital efficiency
3.6% margin — thin
Elevated debt levels
Smaller company, higher risk/reward
ROE of 3.4% — below average capital efficiency
6.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : ZJYL
The strongest argument for ZJYL centers on Price/Book.
Bear Case : MRK
The primary concerns for MRK are Revenue Growth, Return on Equity, Profit Margin. A P/E of 148.4x leaves little room for execution misses. Thin 3.6% margins leave little buffer for downturns.
Bear Case : ZJYL
The primary concerns for ZJYL are Market Cap, Return on Equity, Profit Margin.
Key Dynamics to Monitor
ZJYL carries more volatility with a beta of 7.32 — expect wider price swings.
MRK is growing revenue faster at 4.7% — sustainability is the question.
MRK generates stronger free cash flow (5.5B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (42/100 vs 15/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Jin Medical International Ltd. designs and manufactures wheelchairs and living aids products.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?